Kusajili – Clinical trials directory

Result of your search per sponsor: Tomas Lorant, MD, PhD

Woman and Man Max 99 years
Tomas Lorant, MD, PhD Update Il y a 4 ans

Phase II Study, Evaluation of Safety and Efficacy of IdeS in Chronic Kidney Disease IdeS is an immunoglobulin g (IgG) cleaving enzyme. It will given to patients with donor specific antibodies to reduce the antibody load and thus enable kidney transplantation. IdeS antibod...

Country None
organs None
Specialty None

Closed trial

More information